Oct 2026· Current Issues in Molecular Biology· Vol 48, pp. 1086· 0 citations· 91 references
Medicine
TL;DR
A biologically intertwined relationship between diabetes mellitus and cancer is underscores a biologically intertwined relationship between diabetes mellitus and cancer, supporting the development of integrated therapeutic strategies targeting shared metabolic and signaling mechanisms.
Abstract
Diabetes Mellitus and cancer are major global health problems with rising incidence worldwide. This systematic review was conducted following PRISMA 2020 guidelines by searching PubMed, Scopus, ScienceDirect, SpringerLink, and Google Scholar for studies published between 2015 and 2026. Studies investigating the association between diabetes mellitus and cancer were selected based on predefined criteria, and data were synthesized using a narrative approach. The findings indicate a strong and mechanistically complex association between diabetes mellitus and multiple cancers, particularly pancreatic, breast, colorectal, and prostate cancers. Hyperglycemia, insulin resistance, and chronic inflammation are consistently implicated in tumor initiation and progression through key signaling pathways, including Wnt/β-catenin, PI3K/AKT/mTOR, and AMPK. A bidirectional relationship is most evident in pancreatic cancer, highlighting its unique metabolic and oncogenic interplay. Shared molecular mediators such as cytokines, microRNAs, and metabolic regulators further support a common pathogenic link. Metformin, an antidiabetic drug, demonstrated potential anticancer effects via modulation of these interconnected pathways. Overall, this review underscores a biologically intertwined relationship between diabetes mellitus and cancer, supporting the development of integrated therapeutic strategies targeting shared metabolic and signaling mechanisms.
This review synthesizes current epidemiological, mechanistic, and epigenetic evidence linking diabetes and cancer, with particular emphasis on metabolic-epigenetic crosstalk and clinically relevant signaling pathways, and critically evaluates the dual metabolic and oncologic effects of antidiabetic and anticancer thera...
Prahallad Mishra, T. Pramodkumar, Bhagyashree Pradhan et al.· Diabetes Therapy· 0 citations
Cancer, autoimmune disease and diabetes mellitus are usually studied within separate clinical and scientific traditions, yet they share immune, metabolic and pharmacological pathways that link their occurrence, course and treatment. Epidemiological studies associate type 2 diabetes with an excess risk of several cancer...
Domina Petric· Journal of international res...· 0 citations
The increasing prevalence of type 2 diabetes mellitus (T2DM) represents a significant public health challenge with serious implications for cancer incidence and treatment. Currently affecting over 400 million individuals worldwide, T2DM is characterized by chronic hyperglycemia and insulin resistance, which contribute...
N. Shakour, Fatemeh Hosseini, Zahra Esmaeili et al.· Molecular Aspects of Medicin...· 0 citations
Cancer and hypertension (HTN) frequently coexist, and their relationship is increasingly recognized as a clinically relevant intersection between oncology and cardiovascular medicine. However, the extent to which this association reflects shared risk factors, common biological mechanisms, or treatment‐related effects r...
Pei-Zhi Jia, Da-Xin Chen, Jing-Ting Wang et al.· Cancer Medicine· 0 citations
Type 2 diabetes mellitus (T2DM) and osteoarthritis (OA) are highly prevalent chronic disorders with increasing global burdens that frequently coexist and share common risk factors, including obesity, aging and chronic low-grade inflammation. This narrative review aims to summarize current evidence regarding the epidemi...
Yasir Majeed, G. Schulze-Tanzil, M. Kokozidou· International Journal of Mol...· 0 citations
Diabetes mellitus and pancreatic ductal adenocarcinoma (PDAC) have a bidirectional relationship in which long-standing type 2 diabetes may contribute to cancer susceptibility, while occult pancreatic cancer may induce new-onset diabetes or worsen pre-existing glycemic control. This narrative review critically synthesiz...
Youssef El Marraki, Neima Hassan Aden, Mehdi Toreis et al.· International Journal of Adv...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.